Biotest AG (XTER:BIO3) YoY EBITDA Growth : -73.48% (As of Dec. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Biotest AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Biotest AG's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -73.48%.

Biotest AG's EBITDA per Share for the three months ended in Dec. 2024 was €0.08.

Biotest AG YoY EBITDA Growth Historical Data

The historical data trend for Biotest AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG YoY EBITDA Growth Chart

Biotest AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-66.22

-231.62

235.06

637.82

-33.91

Biotest AG Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															352.42	1,058.04	-15.63	-105.38	-73.48

Biotest AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Biotest AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(3.043	-	4.604)	/	\| 4.604 \|
=	-33.91 %

Biotest AG's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(0.083	-	0.313)	/	\| 0.313 \|
=	-73.48 %

Biotest AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Biotest AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

BTTAY:USA BIESF:USA 0N70:UK BIO3:Austria

Address

Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.

Executives

Dr. Katrin Bernöster	Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke	Senior Vice President plasma alliances and proteine supply
Stephan Fleck	Vice President Corporate Controlling
Dr. Jörg Schüttrumpf	VP Corp. Research &Development
Michael Moritz	VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines